Oryzon Genomics SA (ES:ORY)
BME:ORY
Holding ES:ORY?
Track your performance easily

Oryzon Genomics SA (ORY) Balance Sheet

9 Followers

Oryzon Genomics SA Balance Sheet

Oryzon Genomics SA's total assets for Q4 2022 were €103.70M, an increase of 0.53% from the previous quarter. ES:ORY total liabilities were €31.13M for the fiscal quarter, a -8.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
€ 103.70M€ 95.38M€ 94.11M€ 80.09M€ 67.45M
Total Liabilities
€ 31.13M€ 24.12M€ 18.18M€ 18.97M€ 22.33M
Total Equity Gross Minority
€ 72.57M€ 71.26M€ 75.93M€ 61.13M€ 45.13M
Total Capitalization
€ 79.55M€ 81.61M€ 81.23M€ 64.91M€ 52.52M
Preferred Stock Equity
-----
Capital Lease Obligations
€ 99.09K----
Currency in EUR

Oryzon Genomics SA Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis